Jove
Visualize
Contact Us

Related Concept Videos

Sensitivity, Specificity, and Predicted Value01:13

Sensitivity, Specificity, and Predicted Value

513
In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
513
Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

4.6K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.6K
Volume of Distribution01:20

Volume of Distribution

262
The apparent volume of distribution (Vd) is a crucial pharmacokinetic parameter representing the hypothetical body fluid volume into which a drug disperses. It is calculated based on the total amount of drug in the body (estimated from the administered dose and bioavailability) divided by the plasma drug concentration. The total amount of drug in the body does not directly refer to the dose given but is derived by accounting for absorption, distribution, metabolism, and excretion processes.
262
Receiver Operating Characteristic Plot01:15

Receiver Operating Characteristic Plot

285
A ROC (Receiver Operating Characteristic) plot is a graphical tool used to assess the performance of a binary classification model by illustrating the trade-off between sensitivity (true positive rate) and specificity (false positive rate). By plotting sensitivity against 1 - specificity across various threshold settings, the ROC curve shows how well the model distinguishes between classes, with a curve closer to the top-left corner indicating a more accurate model. The area under the ROC curve...
285
Clinical Trials01:16

Clinical Trials

6.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
6.9K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

150
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
150

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular and Clinical Determinants of Targeted Therapy Treatment in Biliary Tract Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

POLQ-driven repair scars shape the immunogenic landscape of homologous recombination-deficient pancreatic cancer.

bioRxiv : the preprint server for biology·2026
Same author

National Trends in Early-Onset Colorectal Cancer: Incidence and Challenges in the Republic of Ireland.

JCO global oncology·2026
Same author

Acquired High Tumor Mutational Burden and Activity of Immunotherapy after Targeted Therapy in Microsatellite Stable Colorectal Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025
Same author

Clinical Utility and Prognostic Implications of Circulating Cell-Free DNA in Biliary Tract Cancer.

JCO precision oncology·2025
Same author

Intraperitoneal CAR T-cell therapy for peritoneal carcinomatosis from gastroesophageal cancer: preclinical investigations to a phase I clinical trial (NCT06623396).

Journal for immunotherapy of cancer·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 27, 2025

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
03:47

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients

Published on: July 12, 2024

841

Clinical Utility of

Darren Cowzer1, Fergus Keane1, Geoffrey Y Ku1,2

  • 1Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

Diagnostics (Basel, Switzerland)
|June 10, 2023
PubMed
Summary
This summary is machine-generated.

Positron emission tomography-computed tomography (PET-CT) is crucial for managing esophageal and gastroesophageal junction adenocarcinoma. This review highlights its role in staging, prognostication, and guiding therapy for improved patient outcomes.

Keywords:
PET/CTSUVadenocarcinomaesophageal cancerpreoperative treatmentstaging

More Related Videos

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

462
Applications of In Vivo Functional Testing of the Rat Tibialis Anterior for Evaluating Tissue Engineered Skeletal Muscle Repair
07:13

Applications of In Vivo Functional Testing of the Rat Tibialis Anterior for Evaluating Tissue Engineered Skeletal Muscle Repair

Published on: October 7, 2016

14.0K

Related Experiment Videos

Last Updated: Jul 27, 2025

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
03:47

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients

Published on: July 12, 2024

841
Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

462
Applications of In Vivo Functional Testing of the Rat Tibialis Anterior for Evaluating Tissue Engineered Skeletal Muscle Repair
07:13

Applications of In Vivo Functional Testing of the Rat Tibialis Anterior for Evaluating Tissue Engineered Skeletal Muscle Repair

Published on: October 7, 2016

14.0K

Area of Science:

  • Oncology
  • Nuclear Medicine
  • Gastroenterology

Background:

  • Esophageal adenocarcinoma and gastroesophageal junction adenocarcinoma are uncommon but have a rising incidence in young adults.
  • These cancers traditionally have a poor prognosis, with most patients developing metastatic disease despite multimodality treatment.
  • Long-term outcomes for esophageal and GEJ adenocarcinoma remain suboptimal.

Purpose of the Study:

  • To review the key data on the use of PET-CT in managing locally advanced esophageal and GEJ adenocarcinoma.
  • To focus on the applications of PET-CT in staging, prognostication, and therapy adaptation.
  • To discuss the role of PET-CT in neoadjuvant treatment and surveillance strategies.

Main Methods:

  • Review of prospective and retrospective studies evaluating PET-CT in esophageal and GEJ adenocarcinoma.
  • Analysis of data concerning PET-CT's accuracy in staging and prognostication.
  • Evaluation of studies on PET-CT adapted neoadjuvant therapy and surveillance protocols.

Main Results:

  • PET-CT has emerged as a key tool in the management of esophageal and GEJ adenocarcinoma over the last decade.
  • Evidence supports its utility in improving staging accuracy and patient prognostication.
  • PET-CT guided therapy adaptation in the neoadjuvant setting and surveillance shows promise.

Conclusions:

  • PET-CT plays a significant role in the multidisciplinary management of locally advanced esophageal and GEJ adenocarcinoma.
  • Its application in staging, prognostication, and guiding therapy can potentially optimize patient management and outcomes.
  • Further integration of PET-CT in treatment protocols and surveillance is warranted.